|
C14ORF106 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.991100E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.441800E-03 |
| Normal-vs-Stage2 |
2.589000E-04 |
| Normal-vs-Stage3 |
3.741900E-03 |
| Normal-vs-Stage4 |
1.276430E-02 |
| Stage1-vs-Stage2 |
5.408400E-02 |
| Stage1-vs-Stage3 |
5.132400E-01 |
| Stage1-vs-Stage4 |
5.826800E-01 |
| Stage2-vs-Stage3 |
2.026000E-01 |
| Stage2-vs-Stage4 |
2.906400E-01 |
| Stage3-vs-Stage4 |
9.615400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.016800E-03 |
| Normal-vs-AfricanAmerican |
8.475600E-02 |
| Normal-vs-Asian |
5.382700E-03 |
| Caucasian-vs-AfricanAmerican |
9.778400E-01 |
| Caucasian-vs-Asian |
4.214400E-01 |
| AfricanAmerican-vs-Asian |
5.678200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.659500E-03 |
| Normal-vs-Female |
1.020310E-03 |
| Male-vs-Female |
8.199400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.683800E-02 |
| Normal-vs-Age(41-60Yrs) |
2.962600E-04 |
| Normal-vs-Age(61-80Yrs) |
4.403500E-04 |
| Normal-vs-Age(81-100Yrs) |
2.083200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.000400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.591700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.468000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.562400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.382600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.323600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.594400E-01 |
| Classical-VS-Follicular |
1.572290E-04 |
| Classical-VS-Other |
4.580800E-01 |
| Classical-VS-Normal |
1.422140E-02 |
| Tall-VS-Follicular |
1.017780E-02 |
| Tall-VS-Other |
4.129200E-01 |
| Tall-VS-Normal |
2.267800E-01 |
| Follicular-VS-Other |
6.084000E-01 |
| Follicular-VS-Normal |
2.24989999997316E-06 |
| Other-VS-Normal |
1.128040E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.82279999999735E-05 |
| Normal-vs-N1 |
6.623400E-03 |
| N0-vs-N1 |
6.062000E-01 |
|
|
